| Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial AJ Green, JM Gelfand, BA Cree, C Bevan, WJ Boscardin, F Mei, J Inman, ... The Lancet 390 (10111), 2481-2489, 2017 | 354 | 2017 |
| Long‐term evolution of multiple sclerosis disability in the treatment era University of California, San Francisco MS‐EPIC Team:, BAC Cree, ... Annals of neurology 80 (4), 499-510, 2016 | 330 | 2016 |
| Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign HP Mattle, M Arnold, D Georgiadis, C Baumann, K Nedeltchev, ... Stroke 39 (2), 379-383, 2008 | 304 | 2008 |
| Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients A Palanichamy, S Jahn, D Nickles, M Derstine, A Abounasr, SL Hauser, ... The Journal of Immunology 193 (2), 580-586, 2014 | 243 | 2014 |
| B cell exchange across the blood-brain barrier in multiple sclerosis HC von Büdingen, TC Kuo, M Sirota, CJ Van Belle, L Apeltsin, J Glanville, ... The Journal of clinical investigation 122 (12), 4533-4543, 2012 | 233 | 2012 |
| Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation J Glanville, TC Kuo, HC von Büdingen, L Guey, J Berka, PD Sundar, ... Proceedings of the National Academy of Sciences 108 (50), 20066-20071, 2011 | 230 | 2011 |
| Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis A Palanichamy, L Apeltsin, TC Kuo, M Sirota, S Wang, SJ Pitts, ... Science translational medicine 6 (248), 248ra106-248ra106, 2014 | 227 | 2014 |
| Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery F Mei, K Lehmann-Horn, YAA Shen, KA Rankin, KJ Stebbins, DS Lorrain, ... Elife 5, e18246, 2016 | 204 | 2016 |
| Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis PH Lalive, T Menge, C Delarasse, B Della Gaspera, D Pham-Dinh, ... Proceedings of the National Academy of Sciences 103 (7), 2280-2285, 2006 | 201 | 2006 |
| Spinal cord gray matter atrophy correlates with multiple sclerosis disability R Schlaeger, N Papinutto, V Panara, C Bevan, IV Lobach, M Bucci, ... Annals of neurology 76 (4), 568-580, 2014 | 194 | 2014 |
| Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients D Georgiadis, M Arnold, HC Von Buedingen, P Valko, H Sarikaya, ... Neurology 72 (21), 1810-1815, 2009 | 191 | 2009 |
| Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination HCV Bũdingen, N Tanuma, P Villoslada, JC Ouallet, SL Hauser, ... Journal of clinical immunology 21, 155-170, 2001 | 149 | 2001 |
| B lymphocytes in neuromyelitis optica JL Bennett, KC O'Connor, A Bar-Or, SS Zamvil, B Hemmer, TF Tedder, ... Neurology-Neuroimmunology Neuroinflammation 2 (3), 2015 | 130 | 2015 |
| Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity O Stüve, S Youssef, MS Weber, S Nessler, HC von Büdingen, B Hemmer, ... The Journal of clinical investigation 116 (4), 1037-1044, 2006 | 129 | 2006 |
| B cells in multiple sclerosis: connecting the dots HC von Büdingen, A Bar-Or, SS Zamvil Current opinion in immunology 23 (6), 713-720, 2011 | 126 | 2011 |
| Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination HC von Büdingen, SL Hauser, JC Ouallet, N Tanuma, T Menge, ... European journal of immunology 34 (8), 2072-2083, 2004 | 126 | 2004 |
| Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies HC von Büdingen, MD Harrer, S Kuenzle, M Meier, N Goebels European journal of immunology 38 (7), 2014-2023, 2008 | 124 | 2008 |
| Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination HC von Büdingen, SL Hauser, A Fuhrmann, CB Nabavi, JI Lee, ... Proceedings of the National Academy of Sciences 99 (12), 8207-8212, 2002 | 107 | 2002 |
| Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis R Schlaeger, N Papinutto, AH Zhu, IV Lobach, CJ Bevan, M Bucci, ... JAMA neurology 72 (8), 897-904, 2015 | 102 | 2015 |
| Disease-modifying agents for multiple sclerosis: recent advances and future prospects T Menge, MS Weber, B Hemmer, BC Kieseier, HC von Büdingen, ... Drugs 68, 2445-2468, 2008 | 100 | 2008 |
